We are live on
!
Find out more
NICM
Neo Ivy Capital Management Portfolio holdings
AUM
$434M
1-Year Est. Return
44.19%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+44.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
97%
Top 10 Holdings %
Top 10 Hldgs %
17.3%
Holding
278
New
278
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$3.89M |
| 2 |
AT&T
T
|
+$3.66M |
| 3 |
CVS Health
CVS
|
+$3.54M |
| 4 |
Accenture
ACN
|
+$3.24M |
| 5 |
Salesforce
CRM
|
+$3.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Healthcare | 17.6% |
| 3 | Industrials | 10.85% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Financials | 9.79% |
Similar funds
HSA
DCM
SCP
NRC
CEI
CFG
CAAM
OCPWS
Neo Ivy Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Neo Ivy Capital Management held 278 positions worth $190M. Its ten largest holdings account for 17% of the portfolio.
Neo Ivy Capital Management deployed $184M of net new capital in Q2 2023, opening 278 new positions. Its largest new stake was Humana: 7,737 shares worth $3.46M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Healthcare and Industrials.
- Neo Ivy Capital Management's largest Q2 2023 buy was Humana: 7,737 shares worth $3.46M.
- Neo Ivy Capital Management's ten largest holdings make up 17% of its $190M portfolio in Q2 2023.
- Neo Ivy Capital Management opened 278 new positions and closed 0 in Q2 2023.
Based on Neo Ivy Capital Management's 13F filing for Q2 2023, filed 16 Aug 2023.